NCT00161369

Completed

Effect of Homocysteine and Asymmetric Dimethylarginine on Ca...

University of Shizuoka Source

Compare

Other study identifiers

Sponsor study identifier

CT2005001

Study Type

observational

Reported enrollment (type unavailable)

200

Locations

1 country

Sites

1

Timeline

Study Start

April 2000

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

March 2005

Date type not reported

This date has not been verified as actual or estimated.

Brief Summary

Homocysteine (Hcy) and asymmetric dimethylarginine (ADMA) have recently been recognized as potential risk factors for atherosclerosis in the general population, and the metabolism of each of these substances seems to be closely related. This study investigates the association between these substances, and whether elevated serum levels of Hcy and ADMA would be related to a high risk of atherosclerosis and cardiovascular events in maintenance hemodialysis (HD) patients.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Reported enrollment (type unavailable): 200 participants
Study completion date: March 2005
Date type not reported
This date has not been verified as actual or estimated.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
April 2000
Date type not reported
This date has not been verified as actual or estimated.
Study Completion
March 2005
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
September 9, 2005
Actual (reported)
First Posted
September 12, 2005
Actual (reported)

Last Updated: October 21, 2005
Status Verified: October 2005
Last Update Submitted: October 19, 2005

Conditions

Atherosclerosis Chronic Renal Failure Hemodialysis

Keywords

homocysteineasymmetric dimethylarginineatherosclerosiscardiovascular eventhemodialysis

Eligibility Criteria

AgeUp to 70 Years

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may not qualify if:

Any patients showing signs of heart failure or a history of such apparent cardiovascular diseases as myocardial infarction, cardiac valve diseases and stroke were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Maruyama Memorial General Hospital
Othercollaborator
University of Shizuoka
Otherlead
Hamamatsu University

Study Sites (1)

University of Shizuoka

Shizuoka, Shizuoka, 422-8526, Japan

MeSH Terms

Conditions

Kidney Failure, ChronicAtherosclerosis

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsArteriosclerosis

Study Officials

Hiromichi Kumagai, MD
University of Shizuoka
STUDY CHAIR

Study Design

Study Type: observational
Observational Model: DEFINED POPULATION
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER

Study Record Dates

First Submitted

September 9, 2005

First Posted

September 12, 2005

Study Start

April 2000

Date type not reported

This date has not been verified as actual or estimated.

Study Completion

March 2005

Date type not reported

NCT00431899

Effects of Omega 3 in Hemodialysis Patients

Not ApplicableCompleted

NCT00309426

Effect of Fetuin A in Hemodialysis Patients

Unknown

NCT01710020

Pharmacokinetics And Dialysability Of CP-690,550 In Subjects With End-Stage Renal Disease

Phase 1Completed

NCT00295191

Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)

Phase 4Completed

NCT07738731

Dialysis Less Frequently in the Elderly

Not ApplicableNot Yet Recruiting

NCT04877041

Exercise and Cardiac Stunning During HD

Not ApplicableCompleted

Othercollaborator

Arterial Occlusive Diseases

Vascular Diseases

Cardiovascular Diseases

This date has not been verified as actual or estimated.

Last Updated

October 21, 2005

Record last verified: 2005-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00161369
Data provider: ClinicalTrials.gov
Source updated: 2005-10-21
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:31:46 UTC

Locations

JP(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Study Completion

First Submitted

First Posted

Conditions

Keywords

Eligibility Criteria

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

Source record

Locations